BLPH Insider Trading Activity and SEC Form 4 Filings
BLPH insider trading summary
No open-market insider purchases or sales of Bellerophon Therapeutics, Inc. (BLPH) have been reported on SEC Form 4 in the past 12 months.
Latest BLPH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 13, 2023 | Puissance Capital Fund (GP) LLC | 10% Owner | Sell | $112K (1,076,841 @ $0.10) |
| Oct 13, 2023 | Puissance Capital Management LP | 10% Owner | Sell | $112K (1,076,841 @ $0.10) |
| Oct 13, 2023 | Puissance Life Science Opportunities Fund VI | 10% Owner | Sell | $112K (1,076,841 @ $0.10) |
| Oct 13, 2023 | Theodore T Wang | 10% Owner | Sell | $112K (1,076,841 @ $0.10) |
| Jun 7, 2023 | Puissance Life Science Opportunities Fund VI | 10% Owner | Sell | $112K (134,421 @ $0.83) |
| Jun 7, 2023 | Puissance Capital Management LP | 10% Owner | Sell | $112K (134,421 @ $0.83) |
| Jun 7, 2023 | Puissance Capital Fund (GP) LLC | 10% Owner | Sell | $112K (134,421 @ $0.83) |
| Jun 7, 2023 | Theodore T Wang | Director | Sell | $112K (134,421 @ $0.83) |
| May 18, 2023 | Puissance Capital Management LP | 10% Owner | Sell | $5.3M (560,000 @ $9.46) |
| May 18, 2023 | Puissance Capital Fund (GP) LLC | 10% Owner | Sell | $5.3M (560,000 @ $9.46) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.